BA2 Archives - 2021 CMSC Annual Meeting

October 25, 2021

Examining Fatigue in Progressive MS: Results from a Qualitative Study and Review of PRO Measures

Background: Although fatigue is one of the most common symptoms of multiple sclerosis (MS) and several patient-reported outcome (PRO)...

Read More →

Poster-Disease-modifying Therapy

October 25, 2021

Efficacy of Ofatumumab on Microglial Activity in Patients with Relapsing Forms of Multiple Sclerosis: Interim Analysis

INTRODUCTION Ofatumumab, a fully-human anti-CD20 monoclonal antibody, is indicated for the treatment of relapsing forms of multiple...

Read More →

Poster-Family and Caregivers

October 25, 2021

Caregiving Challenges in Multiple Sclerosis and Alzheimers Disease: Results from a Caregiver Survey Study in Two Virtual Communities

Background: Being a caregiver for a family member with a chronic neurological disease is a role that is often simultaneously fulfilling and...

Read More →

Poster-Imaging

October 25, 2021

First Steps Towards Implementation of a Standardized MRI Protocol to Improve Care for People with MS in British Columbia

Background: Magnetic resonance imaging (MRI) is important in the diagnosis and monitoring of people with multiple sclerosis (MS). Using a...

Read More →

Poster-Disease-modifying Therapy

October 25, 2021

Multiple Sclerosis Disease Modifying Therapies Adherence and Total Medical Costs Among Women with Maternity Services Using Administrative Data.

Background: Women with multiple sclerosis (MS) who become pregnant and utilize maternity services may find their use of disease-modifying...

Read More →

Poster-Disease-modifying Therapy

October 25, 2021

Adherence to Multiple Sclerosis Disease Modifying Therapies Using Pharmacy Quality Alliance Criteria and Medical Costs or Hospitalizations in an Administrative Database.

Background: Evidence is needed that adherence to disease-modifying therapies (DMT) for multiple sclerosis (MS) can reduce total medical...

Read More →

2021 CMSC Annual Meeting

Tag: BA2

Examining Fatigue in Progressive MS: Results from a Qualitative Study and Review of PRO Measures

Efficacy of Ofatumumab on Microglial Activity in Patients with Relapsing Forms of Multiple Sclerosis: Interim Analysis

Caregiving Challenges in Multiple Sclerosis and Alzheimers Disease: Results from a Caregiver Survey Study in Two Virtual Communities

First Steps Towards Implementation of a Standardized MRI Protocol to Improve Care for People with MS in British Columbia

Multiple Sclerosis Disease Modifying Therapies Adherence and Total Medical Costs Among Women with Maternity Services Using Administrative Data.

Adherence to Multiple Sclerosis Disease Modifying Therapies Using Pharmacy Quality Alliance Criteria and Medical Costs or Hospitalizations in an Administrative Database.

MAILING ADDRESS

CONTACT US

FOLLOW US

2021 CMSC Annual Meeting

Tag: BA2

Examining Fatigue in Progressive MS: Results from a Qualitative Study and Review of PRO Measures

Efficacy of Ofatumumab on Microglial Activity in Patients with Relapsing Forms of Multiple Sclerosis: Interim Analysis

Caregiving Challenges in Multiple Sclerosis and Alzheimers Disease: Results from a Caregiver Survey Study in Two Virtual Communities

First Steps Towards Implementation of a Standardized MRI Protocol to Improve Care for People with MS in British Columbia

Multiple Sclerosis Disease Modifying Therapies Adherence and Total Medical Costs Among Women with Maternity Services Using Administrative Data.

Adherence to Multiple Sclerosis Disease Modifying Therapies Using Pharmacy Quality Alliance Criteria and Medical Costs or Hospitalizations in an Administrative Database.

MAILING ADDRESS

CONTACT US

FOLLOW US

Caregiving Challenges in Multiple Sclerosis and Alzheimers Disease: Results from a Caregiver Survey Study in Two Virtual Communities

Multiple Sclerosis Disease Modifying Therapies Adherence and Total Medical Costs Among Women with Maternity Services Using Administrative Data.